Agios Pharmaceuticals reported $0 in Cash and Equivalent for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 283M 6M
Alexion Pharmaceuticals ALXN:US $ 2825M 510M
Alnylam Pharmaceuticals ALNY:US $ 496.7M 84.12M
Amgen AMGN:US $ 9145M 1458M
AstraZeneca AZN:LN 8072M 2399M
Bayer BAYN:GR € 3148M 859M
Biogen BIIB:US $ 2224.8M 160.1M
Biomarin Pharmaceutical BMRN:US $ 818.9M 342.27M
Bluebird Bio BLUE:US $ 1198.77M 852.14M
Bristol Myers Squibb BMY:US $ 19934M 4117M
Daiichi Sankyo 4568:JP Y 382102M 42082M
Eli Lilly And LLY:US $ 2365.1M 666.1M
Exelixis EXEL:US $ 527M 170M
Gilead Sciences GILD:US $ 6746M 3305M
GlaxoSmithKline GSK:LN 8166M 3397M
Immunogen IMGN:US $ 188.22M 31.29M
Merk MRK:US $ 11103M 3678M
Novartis NVS:US $ 8994M 3077M
Pfizer PFE:US $ 1801M 350M
Puma Biotechnology PBYI:US $ 90M 7M
Regeneron Pharmaceuticals REGN:US $ 1992.2M 216M
Sarepta Therapeutics SRPT:US $ 1639M 125M
Seattle Genetics SGEN:US $ 919.45M 802.13M
Vertex Pharmaceuticals VRTX:US $ 4831.33M 1237.92M
YTE INCY:US $ 1326.73M 283.49M